EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of type I PRMTs reforms muscle stem cell identity enhancing their therapeutic capacity

Claudia Dominici, Oscar D Villarreal, Junio Dort, Emilie Heckel, Yu Chang Wang, Ioannis Ragoussis, Jean-Sebastien Joyal, Nicolas Dumont, Stéphane Richard iD

eLife · 2023

DOI: 10.7554/elife.84570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Claudia Dominici und 8 weiteren Autor:innen. Beteiligte Einrichtung: Segal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Satellite Cells, Skeletal Muscle, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In skeletal muscle, muscle stem cells (MuSC) are the main cells responsible for regeneration upon injury. In diseased skeletal muscle, it would be therapeutically advantageous to replace defective MuSCs, or rejuvenate them with drugs to enhance their self-renewal and ensure long-term regenerative potential. One limitation of the replacement approach has been the inability to efficiently expand MuSCs ex vivo, while maintaining their stemness and engraftment abilities. Herein, we show that inhibition of type I protein arginine methyltransferases (PRMTs) with MS023 increases the proliferative capacity of ex vivo cultured MuSCs. Single cell RNA sequencing (scRNAseq) of ex vivo cultured MuSCs revealed the emergence of subpopulations in MS023-treated cells which are defined by elevated Pax7 expression and markers of MuSC quiescence, both features of enhanced self-renewal. Furthermore, the scRNAseq identified MS023-specific subpopulations to be metabolically altered with upregulated glycolysis and oxidative phosphorylation (OxPhos). Transplantation of MuSCs treated with MS023 had a better ability to repopulate the MuSC niche and contributed efficiently to muscle regeneration following injury. Interestingly, the preclinical mouse model of Duchenne muscular dystrophy had increased grip strength with MS023 treatment. Our findings show that inhibition of type I PRMTs increased the proliferation capabilities of MuSCs with altered cellular metabolism, while maintaining their stem-like properties such as self-renewal and engraftment potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Satellite Cells, Skeletal MuscleMuscular Dystrophy, DuchenneAnimalsMiceMuscle, SkeletalCells, CulturedProtein-Arginine N-Methyltransferases

Stichwörter der Autor:innen

MS023arginine methylationduchenne muscular dystrophymousemuscle stem cellregenerative medicineskeletal musclestem cellstype I PRMT

Substanzen

Protein-Arginine N-Methyltransferases

Autor:innen und Institutionen

  • Segal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada.
  • Departments of Human Genetics, McGill University, Montreal, Canada.
  • CHU Sainte-Justine Research Center, Université de Montréal, Montréal, Canada.
  • Genome Quebec Innovation Centre, Montreal, Canada.
  • Gerald Bronfman, Department of Oncology, McGill University, Montréal, Canada.
  • Departments of Medicine, McGill University, Montreal, Canada.

ORCID-Profile: Stéphane Richard

Förderung

  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Dominici, C., Villarreal, O. D., Dort, J., Heckel, E., Wang, Y. C., Ragoussis, I., Joyal, J. S., Dumont, N., & Richard, S. (2023). Inhibition of type I PRMTs reforms muscle stem cell identity enhancing their therapeutic capacity. eLife. https://doi.org/10.7554/elife.84570

Vancouver

Dominici C, Villarreal OD, Dort J, Heckel E, Wang YC, Ragoussis I, et al. Inhibition of type I PRMTs reforms muscle stem cell identity enhancing their therapeutic capacity. eLife. 2023. doi:10.7554/elife.84570

BibTeX
@article{Dominici2023,
  author = {Dominici, Claudia and Villarreal, Oscar D and Dort, Junio and Heckel, Emilie and Wang, Yu Chang and Ragoussis, Ioannis and Joyal, Jean-Sebastien and Dumont, Nicolas and Richard, Stéphane},
  title = {Inhibition of type I PRMTs reforms muscle stem cell identity enhancing their therapeutic capacity},
  journal = {eLife},
  year = {2023},
  doi = {10.7554/elife.84570}
}
Kostenlos starten →